The purpose of this CGA is to encourage Organizations to submit medical education grant applications for independent CME/CE certified education designed to close an independently identified education gap, drive measurable improvements in competence and performance of healthcare professionals, and enhance understanding of the management for HSPC for both HCP and patient/caregiver audiences. Grant proposals should leverage innovative data delivery mechanisms including an omnichannel approach. Knowledge gaps in earlier stage prostate cancer (HSPC) which have been identified in the public healthcare landscape include:
• Identification and stratification of high risk nmHSPC, particularly high-risk biochemical recurrence (BCR) and associated treatment strategies.
• Knowledge of approved treatment options including the role of treatment intensification in HSPC.
• How HCP’s early treatment decisions may have subsequent impact on future therapeutic options across the disease continuum.
• Novel decision-making tools for HCPs to use which support shared clinical decision making and drive patient engagement in their care.